Naslov
PREDNOSTI HUMANOG EPIDIDIMALOG PROTEINA (HE4) U ODNOSU NA TRADICIONALNO KORIŠTENE TUMORSKE MARKERE U GINEKOLOŠKOJ ONKOLOGIJI
(BENEFITS HUMAN EPIDYDIMIS PROTEIN (HE4) COMPARED TO TRADITIONAL USED TUMOR MARKERS IN GYNECOLOGICAL ONCOLOGY)

Autori
Špacir Prskalo, Zvjezdana ; Gaće, Mihaela ; Dobrijević, Sanja ; Mayer, Ljiljana

Izvornik
Libri oncologici : Croatian journal of oncology (0300-8142) 43 (2015), 1-3; 9-14

Vrsta, podvrsta i kategorija rada
Radovi u časopisima, pregledni rad, stručni

Ključne riječi
rak jajnika, CEA 125, HE4 (Humani epidimelni protein), ROMA index
(ovarian cancer, CA125, HE4 (Human epidydimis protein), ROMA (Risk of Ovarian Malignancy Algorithm) index)

Sažetak
Ovarian cancer is, with its high incidence and mortality, a worldwide problem. One reason for this is the lack of symptoms. The second reason is practically non-existant screening for ovarian cancer. Until recently, the only routinely used marker for ovarian abnormalities was CA125. Determination of HE4 levels, together with those of CA125 and the calculation of the ROMA index, is a suitable method for improving primary detection of ovarian cancer. The measurement of serum HE4 is a useful method for diff erential diagnosis between benign gynecologic disease and ovarian cancer

Izvorni jezik
Engleski

Znanstvena područja
Temeljne medicinske znanosti, Kliničke medicinske znanosti, Javno zdravstvo i zdravstvena zaštita

POVEZANOST RADA